Federal Register / Vol. 79, No. 65 / Friday, April 4, 2014 / Notices 18913 

to charge registration fees, and, if so, 

state that the co-sponsor agrees to set a 

fee no higher than necessary to recover 

its share of the costs of the event; (b) 

state whether HHS and the co-sponsor 

agree that HHS employees will be 

allowed free attendance at the event; (c) 

state whether the co-sponsor intends to 

sell educational materials pertaining to 

the event or transcripts or recordings of 

the event, and, if so, state that the cosponsor agrees to sell such items at 

cost.] 

4. Independently Sponsored Portions of 

Event 

[Provide the following information: 

(a) State whether either HHS or the cosponsor intends to sponsor any discrete 

portion of the event independently; (b) 

describe any separately sponsored 

portion; (c) state that HHS resources, 

including staff, will not be used to 

develop, promote or otherwise support 

a portion of the event that is 

independently sponsored by the cosponsor, although official 

announcements and brochures may 

contain factual references to the 

schedule of the entire event, including 

portions sponsored solely by the cosponsor.] 

5. Fundraising 

[Name of co-sponsor] will make clear, 

in any solicitation for funds to cover its 

share of the event costs, that it, not 

HHS, is asking for the funds. [Name of 

co-sponsor] will not imply that HHS 

endorses any fundraising activities in 

connection with the event. [Name of cosponsor] will make clear to donors that 

any gift will go solely toward defraying 

the expenses of [name of co-sponsor], 

not HHS. 

6. Promotional Activity 

[Name of co-sponsor] will not use the 

event primarily as a vehicle to sell or 

promote products or services. [Name of 

co-sponsor] will ensure that any 

incidental promotional activity does not 

imply that HHS endorses any products 

or services. [Name of co-sponsor] will 

make reasonable efforts, subject to HHS 

review, to segregate any incidental 

promotional activity from the main 

activities of the event. 

7. Event Publicity and Endorsements 

[Name of co-sponsor] will not use the 

name of HHS or any of its components, 

except in factual publicity for the 

specific event. Factual publicity 

includes dates, times, locations, 

purposes, agendas, fees, and speakers 

involved with the event. Such factual 

publicity shall not imply that the 

involvement of HHS in the event serves 

as an endorsement of the general 

policies, activities, or products of [name 

of co-sponsor]; where confusion could 

result, publicity should be accompanied 

by a disclaimer to the effect that no 

endorsement is intended. [Name of cosponsor] will clear all publicity 

materials for the event with HHS to 

ensure compliance with this paragraph. 

8. Records 

Records concerning the event shall 

account fully and accurately for the 

financial commitments and 

expenditures of HHS and [name of cosponsor]. Such records shall reflect, at a 

minimum, the amounts, sources, and 

uses of all funds. 

9. Public Availability 

This co-sponsorship agreement, as 

well as the financial records described 

in paragraph 8, shall be publicly 

available. 

10. Co-Sponsorship Guidance 

HHS and [name of co-sponsor] will 

abide by the legal memorandum of 

August 8, 2002, entitled ‘‘CoSponsorship Guidance,’’ issued by the 

HHS Designated Agency Ethics Official. 

Co-Sponsorship Proposal: Each cosponsorship proposal shall contain a 

description of: (1) The entity or 

organization’s background and history, 

(2) its ability to satisfy the cosponsorship criteria detailed above, and 

(3) its proposed involvement in the cosponsored activity. 

Evaluation Criteria: After engaging in 

exploratory discussions with potential 

co-sponsors that respond to this notice, 

AHRQ will select the co-sponsor or cosponsors using the following evaluation 

criteria: 

(1) Qualifications and capability to 

fulfill co-sponsorship responsibilities; 

(2) Creativity related to enhancing the 

conference, including options for 

interactive sessions and ideas for 

improving the event based on the 2012 

conference offerings; 

(3) Potential for reaching and 

generating attendees from among key 

stakeholders, including Federal, State 

and local policymakers, health care 

providers, consumers and patients, 

purchasers and payers, and other health 

officials and underserved/special 

populations; 

(4) Experience administering 

conferences; 

(5) Past or current work specific to 

health services research; 

(6) Personnel names, professional 

qualifications, and specific expertise 

with conference planning; 

(7) Availability and description of 

facilities needed to participate in and 

support the conference planning 

process, including office space, 

information technology, and 

telecommunication resources; 

(8) Description of financial 

management expertise, including 

demonstration of experience in 

developing a budget and collecting and 

managing monies from organizations 

and individuals; and, 

(9) Proposed plan for managing a 

conference with AHRQ. 

Dated: March 28, 2014. 

Richard Kronick, 

Director, Agency for Healthcare Research and 

Quality. 

[FR Doc. 2014–07562 Filed 4–3–14; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10421] 

Emergency Clearance: Public 

Information Collection Requirements 

Submitted to the Office of Management 

and Budget (OMB) 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

In compliance with section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, the Centers for 

Medicare & Medicaid Services (CMS), 

Department of Health and Human 

Services, is publishing a summary of 

this proposed information collection for 

public comment. Interested persons are 

invited to send comments regarding this 

collection’s proposed burden estimates 

or any other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

In compliance with section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, we have also 

submitted to the Office of Management 

and Budget (OMB) the proposed 

information collection for their 

emergency review. While the 

information collection request (ICR) is 

necessary to ensure compliance with an 

initiative of the Administration, we are 

requesting emergency review of the ICR 

mstockstill on DSK4VPTVN1PROD with NOTICES

18914 Federal Register / Vol. 79, No. 65 / Friday, April 4, 2014 / Notices 

for the Medicare Fee-for-Service 

Recovery Audit Prepayment Review 

Demonstration and Prior Authorization 

Demonstration be processed under the 

emergency clearance process associated 

with 5 CFR 1320.13(a)(2)(i) and 5 CFR 

1320.13(a)(2)(ii). However, the revisions 

contained in this request only pertain to 

the Prior Authorization of Power 

Mobility Device (PMD) Demonstration. 

The approval of the revisions to this 

ICR is essential to prevent improper 

payments for PMDs that do not meet 

Medicare coverage requirements. We 

believe that this demonstration prevents 

public harm by protecting the Medicare 

Trust Fund from improper payments 

made for PMDs that do not comply with 

Medicare policy and by ensuring that a 

beneficiary’s medical condition 

warrants the medical equipment 

ordered. Reductions in improper 

payments will help ensure the 

sustainability of the Medicare Trust 

Fund and protect beneficiaries who 

depend upon the Medicare program. In 

absence of this expanded 

demonstration, a significant number of 

claims will not be reviewed to ensure 

compliance with § 1862(a)(l)(A) of the 

Act which provides that Medicare may 

only make payment for services which 

are reasonable and necessary for the 

diagnosis or treatment of illness or 

injury or to improve the functioning of 

a malformed body member. 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Fee-for-Service 

Recovery Audit Prepayment Review 

Demonstration and Prior Authorization 

Demonstration; Use: On July 23, 2012, 

the Office of Management and Budget 

approved the collections required for 

two demonstrations of prepayment 

review and prior authorization. The first 

demonstration allows Medicare 

Recovery Auditors to review claims on 

a pre-payment basis in certain States. 

The second demonstration established a 

prior authorization program for Power 

Mobility Device claims in certain States. 

For the Recovery Audit Prepayment 

Review Demonstration, CMS and its 

agents request additional 

documentation, including medical 

records, to support submitted claims. As 

discussed in more detail in Chapter 3 of 

the Program Integrity Manual, 

additional documentation includes any 

medical documentation, beyond what is 

included on the face of the claim that 

supports the item or service that is 

billed. For Medicare to consider 

coverage and payment for any item or 

service, the information submitted by 

the provider or supplier (e.g., claims) 

must be supported by the 

documentation in the patient’s medical 

records. When conducting complex 

medical review, the contractor specifies 

documentation they require in 

accordance with Medicare’s rules and 

policies. In addition, providers and 

suppliers may supply additional 

documentation not explicitly listed by 

the contractor. This supporting 

information may be requested by CMS 

and its agents on a routine basis in 

instances where diagnoses on a claim do 

not clearly indicate medical necessity, 

or if there is a suspicion of fraud. 

For the Prior Authorization of Power 

Mobility Devices (PMDs) 

Demonstration, we are piloting prior 

authorization for PMDs. Prior 

authorization will allow the applicable 

documentation that supports a claim to 

be submitted before the item is 

delivered. For prior authorization, 

relevant documentation for review is 

submitted before the item is delivered or 

the service is rendered. CMS will 

conduct this demonstration in 

California, Florida, Illinois, Michigan, 

New York, North Carolina and Texas 

based on beneficiary address as reported 

to the Social Security Administration 

and recorded in the Common Working 

File (CWF). For the demonstration, a 

prior authorization request can be 

completed by the (ordering) physician 

or treating practitioner and submitted to 

the appropriate DME MAC for an initial 

decision. The supplier may also submit 

the request on behalf of the physician or 

treating practitioner. The physician, 

treating practitioner or supplier who 

submits the request on behalf of the 

physician or treating practitioner, is 

referred to as the ‘‘submitter.’’ Under 

this demonstration, the submitter will 

submit to the DME MAC a request for 

prior authorization and all relevant 

documentation to support Medicare 

coverage of the PMD item. 

With this emergency Federal Register 

notice, we are announcing our plans to 

expand the demonstration from the 

seven aforementioned States to 12 new 

States, bringing the total number of 

participating States to 19; however, the 

original demonstration requirements 

will remain the same in all 19 States. 

The new States include Pennsylvania, 

Ohio, Louisiana, Missouri, Maryland, 

New Jersey, Indiana, Kentucky, Georgia, 

Tennessee, Washington, and Arizona. 

Form Number: CMS–10421 (OCN: 

0938–1169); Frequency: Occasionally; 

Affected Public: State, Local or Tribal 

Governments; Number of Respondents: 

333,750; Total Annual Responses: 

333,750; Total Annual Hours: 170,060. 

(For policy questions regarding this 

collection contact Daniel Schwartz at 

410–786–4197. For all other issues call 

410–786–1326.) 

We are requesting OMB review and 

approval of this collection by April 18, 

2014, with a 180-day approval period. 

Written comments and 

recommendations will be considered 

from the public if received by the date 

and address noted below. 

Copies of the supporting statement 

and any related forms can be found at: 

http://www.cms.hhs.gov/

PaperworkReductionActof1995 or can 

be obtained by emailing your request, 

including your address, phone number, 

OMB number, and CMS document 

identifier, to: Paperwork@cms.hhs.gov, 

or by calling the Reports Clearance 

Office at: 410–786–1326. 

When commenting on this proposed 

information collection, please reference 

the CMS document identifier and the 

OMB control number (OCN). To be 

assured consideration, comments and 

recommendations must be received in 

one of the following ways by April 18, 

2014: 

1. Electronically. You may submit 

your comments electronically to http:// 

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) accepting comments. 

2. By regular mail. You may mail 

written comments to the following 

address: 

CMS, Office of Strategic Operations and 

Regulatory Affairs, Division of 

Regulations Development, Attention: 

Document Identifier (CMS–10421), 

Room C4–26–05, 7500 Security 

Boulevard, Baltimore, Maryland 

21244–1850 and, 

OMB Office of Information and 

Regulatory Affairs, Attention: CMS 

Desk Officer, New Executive Office 

Building, Room 10235, Washington, 

DC 20503, Fax Number: 202–395– 

6974. 

Dated: April 1, 2014. 

Martique Jones, 

Deputy Director, Regulations Development 

Group, Office of Strategic Operations and 

Regulatory Affairs. 

[FR Doc. 2014–07577 Filed 4–3–14; 8:45 am] 

BILLING CODE 4120–01–P 

mstockstill on DSK4VPTVN1PROD with NOTICES